These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11818148)

  • 41. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
    Perales MA; Schwartz DH; Fabry JA; Lieberman J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):27-35. PubMed ID: 7648281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced Immune Responses to HIV-1 Envelope Elicited by a Vaccine Regimen Consisting of Priming with Newcastle Disease Virus Expressing HIV gp160 and Boosting with gp120 and SOSIP gp140 Proteins.
    Khattar SK; DeVico AL; LaBranche CC; Panda A; Montefiori DC; Samal SK
    J Virol; 2016 Feb; 90(3):1682-6. PubMed ID: 26581986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
    Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transgene vaccination using Ulex europaeus agglutinin I (UEA-1) for targeted mucosal immunization against HIV-1 envelope.
    Wang X; Kochetkova I; Haddad A; Hoyt T; Hone DM; Pascual DW
    Vaccine; 2005 May; 23(29):3836-42. PubMed ID: 15893622
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons.
    Corbet S; Vinner L; Hougaard DM; Bryder K; Nielsen HV; Nielsen C; Fomsgaard A
    AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1997-2008. PubMed ID: 11153083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunization with HIV-1 subtype B gp160-DNA induces specific as well as cross reactive immune responses in mice.
    Arora A; Seth P
    Indian J Med Res; 2001 Jul; 114():1-9. PubMed ID: 11762199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.
    Lu Y; Xin KQ; Hamajima K; Tsuji T; Aoki I; Yang J; Sasaki S; Fukushima J; Yoshimura T; Toda S; Okada E; Okuda K
    Clin Exp Immunol; 1999 Feb; 115(2):335-41. PubMed ID: 9933462
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice.
    Bråve A; Boberg A; Gudmundsdotter L; Rollman E; Hallermalm K; Ljungberg K; Blomberg P; Stout R; Paulie S; Sandström E; Biberfeld G; Earl P; Moss B; Cox JH; Wahren B
    Mol Ther; 2007 Sep; 15(9):1724-33. PubMed ID: 17579577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses.
    Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M
    Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of the rev gene to the immunogenicity of DNA vaccines targeting the envelope glycoprotein of HIV.
    Jounai N; Okuda K; Kojima Y; Toda Y; Hamajima K; Ohba K; Klinman D; Xin KQ
    J Gene Med; 2003 Jul; 5(7):609-17. PubMed ID: 12825200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant action of murine IL-2/Ig plasmid after intramuscular immunization with Indian HIV-1 subtype C recombinant env.gp 120 construct.
    Aggarwal P; Kumar S; Vajpayee M; Seth P
    Viral Immunol; 2005; 18(4):649-56. PubMed ID: 16359231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of cytokine synergy essential for vaccine protection against viral challenge.
    Ahlers JD; Belyakov IM; Matsui S; Berzofsky JA
    Int Immunol; 2001 Jul; 13(7):897-908. PubMed ID: 11431420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg.
    He XW; Wang F; Jiang L; Li J; Liu SK; Xiao ZY; Jin XQ; Zhang YN; He Y; Li K; Guo YJ; Sun SH
    J Gen Virol; 2005 Mar; 86(Pt 3):601-610. PubMed ID: 15722520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunogenicity of plasmid DNA and adenoviral vectors encoding HIV-1 subtype B env gene].
    Yang HR; Zhang LF; Feng X; Yu SQ; Zhuang ZL; Li HX; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):415-7. PubMed ID: 21604562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses.
    Hallengärd D; Applequist SE; Nyström S; Maltais AK; Marovich M; Moss B; Earl P; Nihlmark K; Wahren B; Bråve A
    Viral Immunol; 2012 Oct; 25(5):423-32. PubMed ID: 23035853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits.
    Rangasamy SP; Menon V; Dhopeshwarkar P; Pal R; Vaniambadi KS; Mahalingam S
    Vaccine; 2016 May; 34(21):2444-2452. PubMed ID: 27032514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improvement of antibody responses by HIV envelope DNA and protein co-immunization.
    Pissani F; Malherbe DC; Schuman JT; Robins H; Park BS; Krebs SJ; Barnett SW; Haigwood NL
    Vaccine; 2014 Jan; 32(4):507-13. PubMed ID: 24280279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.
    Khattar SK; Palaniyandi S; Samal S; LaBranche CC; Montefiori DC; Zhu X; Samal SK
    Hum Vaccin Immunother; 2015; 11(2):504-15. PubMed ID: 25695657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.